Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash | 0.13 | 0.02 | 1.21 | 0.82 |
Short Term Investments | 2.33 | 1.36 | 1.37 | 0.44 |
Cashand Short Term Investments | 2.46 | 1.38 | 5.18 | 2.14 |
Accounts Receivable- Trade Net | 16.32 | 12.75 | 17.66 | 13.70 |
Total Receivables Net | 16.32 | 12.75 | 17.66 | 13.70 |
Total Inventory | 9.61 | 11.30 | 27.52 | 23.60 |
Other Current Assets Total | 2.66 | 1.86 | 10.29 | 8.36 |
Total Current Assets | 31.05 | 27.61 | 61.18 | 47.80 |
Property/ Plant/ Equipment Total- Net | 13.60 | 14.81 | 124.49 | 107.70 |
Intangibles Net | 0.07 | 0.20 | 0.63 | 0.69 |
Long Term Investments | 43.05 | 64.19 | 0.28 | 1.35 |
Note Receivable- Long Term | 2.68 | 2.79 | 3.58 | 2.02 |
Other Long Term Assets Total | 0.00 | 0.00 | 5.75 | 2.52 |
Total Assets | 90.45 | 109.60 | 195.91 | 162.08 |
Accounts Payable | 15.44 | 23.37 | 28.00 | 30.95 |
Current Portof LT Debt/ Capital Leases | 5.29 | 0.25 | 4.07 | 3.31 |
Other Currentliabilities Total | 2.32 | 2.84 | 5.65 | 15.82 |
Total Current Liabilities | 23.05 | 33.02 | 48.88 | 63.71 |
Long Term Debt | 0.00 | 0.00 | 9.29 | 14.43 |
Capital Lease Obligations | 0.36 | 0.60 | 0.85 | 0.01 |
Total Long Term Debt | 0.36 | 0.60 | 10.14 | 14.44 |
Total Debt | 5.64 | 6.51 | 25.26 | 31.38 |
Minority Interest | 0.00 | 0.00 | 71.27 | - |
Other Liabilities Total | 1.46 | 2.02 | 2.57 | 1.54 |
Total Liabilities | 24.86 | 35.64 | 132.86 | 82.93 |
Common Stock Total | 26.25 | 24.70 | 24.70 | 24.70 |
Retained Earnings( Accumulated Deficit) | 39.34 | -19.10 | -30.04 | 54.45 |
Total Equity | 65.59 | 73.95 | 63.05 | 79.15 |
Total Liabilities Shareholders' Equity | 90.45 | 109.60 | 195.91 | 162.08 |
Total Common Shares Outstanding | 2.62 | 2.49 | 2.49 | 2.49 |
Tangible Book Valueper Share Common Eq | 24.96 | 29.57 | 25.03 | 31.46 |
Prepaid Expenses | - | 0.31 | 0.53 | - |
Property/ Plant/ Equipment Total- Gross | - | 43.08 | 156.93 | 0.68 |
Accumulated Depreciation Total | - | -28.27 | -32.44 | - |
Accrued Expenses | - | 0.90 | 0.11 | - |
Notes Payable/ Short Term Debt | - | 5.66 | 11.05 | 13.64 |
Additional Paid- In Capital | - | 68.00 | 68.00 | - |
Other Equity Total | - | 0.35 | 0.38 | - |
Cash Equivalents | - | - | 2.61 | 0.88 |
Deferred Income Tax | - | - | 0.00 | 3.23 |
Brooks Laboratories Dividend Brooks Laboratories Bonus Brooks Laboratories News Brooks Laboratories AGM Brooks Laboratories Rights Brooks Laboratories Splits Brooks Laboratories Board Meetings Brooks Laboratories Key Metrics Brooks Laboratories Shareholdings Brooks Laboratories Profit Loss Brooks Laboratories Cashflow Brooks Laboratories Q1 Results Brooks Laboratories Q2 Results Brooks Laboratories Q3 Results Brooks Laboratories Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks